Mito.Tech Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Mito.Tech General Information
Description
Operator of a biotechnology platform intended to develop mitochondria-focused treatments for obesity and metabolic dysfunction-associated steatohepatitis (MASH). The company offers small-molecule drug candidates designed to increase cellular energy expenditure, enabling pharmaceutical companies and healthcare researchers to investigate potential treatments for metabolic diseases.
Contact Information
Website
www.mitotechpharma.comCorporate Office
- 9, Jerdan Place
- Suite 144
- London SW6 1BE
- England, United Kingdom
Corporate Office
- 9, Jerdan Place
- Suite 144
- London SW6 1BE
- England, United Kingdom
Mito.Tech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 15-Oct-2025 | Completed | Clinical Trials - Phase 1 | |||
| 2. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 1. Later Stage VC | 28-Aug-2018 | $17M | $17M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Mito.Tech Comparisons
Industry
Financing
Details
Mito.Tech Competitors (19)
One of Mito.Tech’s 19 competitors is CSL Behring, a Corporation company based in King Of Prussia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CSL Behring | Corporation | King Of Prussia, PA | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Oxcia AB (publ) | Corporation | Stockholm, Sweden | ||||
| Merck & Co. | Corporation | Rahway, NJ |
Mito.Tech Patents
Mito.Tech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260217746-A1 | Crystalline forms of antioxidant compound | Pending | 16-Aug-2024 | ||
| AU-2025241722-A1 | Treatment and prevention of obesity using a combination of mitochondrial uncouplers and glucagon-like peptide-1 receptor agonists | Pending | 18-Mar-2024 | ||
| WO-2025196507-A1 | Treatment and prevention of obesity using a combination of mitochondrial uncouplers and glucagon-like peptide-1 receptor agonists | Pending | 18-Mar-2024 | ||
| US-12077553-B1 | Crystalline form of antioxidant compound | Active | 09-Nov-2023 | ||
| AU-2024378319-A1 | Crystalline forms of antioxidant compound | Pending | 09-Nov-2023 | C07F9/5442 |
Mito.Tech Signals
Mito.Tech Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Essex Bio-technology | Corporation | Minority | ||
| MSU Science Park | Accelerator/Incubator |
Mito.Tech FAQs
-
When was Mito.Tech founded?
Mito.Tech was founded in 2010.
-
Where is Mito.Tech headquartered?
Mito.Tech is headquartered in London, United Kingdom.
-
What is the size of Mito.Tech?
Mito.Tech has 6 total employees.
-
What industry is Mito.Tech in?
Mito.Tech’s primary industry is Drug Discovery.
-
Is Mito.Tech a private or public company?
Mito.Tech is a Private company.
-
What is Mito.Tech’s current revenue?
The current revenue for Mito.Tech is .
-
How much funding has Mito.Tech raised over time?
Mito.Tech has raised $17M.
-
Who are Mito.Tech’s investors?
Essex Bio-technology and MSU Science Park have invested in Mito.Tech.
-
Who are Mito.Tech’s competitors?
CSL Behring, Bristol-Myers Squibb, Genentech, Oxcia AB (publ), and Merck & Co. are some of the 19 competitors of Mito.Tech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process